Introduction {#sec1}
============

Malaria is a life-threatening disease caused by *Plasmodium* parasites, which is transmitted among people through the bites of infected female *Anopheles* mosquitoes \[[@ref1]\]. Among the five *Plasmodium* species known to be infectious for humans \[[@ref2]\], *Plasmodium falciparum* and *Plasmodium vivax* are the two main species of parasites that pose the greatest threat worldwide \[[@ref1], [@ref3]\]. Malaria is usually an acute febrile illness with symptoms such as fever, headache and chills typically appearing 10--15 days after the individual has been infected. If not treated within 24 h, cases of *P. falciparum* malaria can progress to severe illness and even death \[[@ref1], [@ref3]\].

In 2016, the World Health Organization (WHO) indicated that nearly half of the world\'s population was at risk of malaria \[[@ref1]\], and there were an estimated 216 (196--263, 95% confidence interval (CI)) million cases of malaria in 91 countries. It was estimated that 435 000 deaths from malaria had occurred in 2017 globally \[[@ref4]\]. Despite being preventable and treatable, malaria continues to have a devastating impact on human health around the world \[[@ref5]\]. China has a long history of struggling with infectious diseases, and historically, malaria had been widespread in China, especially in the early 1970s. Over the past decades, China has adopted comprehensive intervention policies and strategies \[[@ref6], [@ref7]\].

The vision of the WHO and the global malaria community is a world free of malaria \[[@ref5]\]. In 1955, the WHO launched the Global Malaria Eradication Programme (GMEP), which was an ambitious plan to eradicate malaria worldwide \[[@ref3]\]. As of 2000, eight countries had eliminated malaria, and many other countries had reduced the transmission to low levels (\<100 indigenous malaria cases per year) \[[@ref5]\]. In 2016, China was identified as one of the 21 countries that had the potential to eliminate malaria by 2020 \[[@ref3]\]. To meet the certification criteria for malaria elimination, a country must prove that the chain of indigenous malaria transmission by *Anopheles* mosquitoes has been interrupted nationwide (i.e., reducing the rate of malaria cases to zero) for at least three consecutive years. Continued measures are required to prevent the re-establishment of transmission \[[@ref3], [@ref8]\].

To summarise the long-term disease burden of malaria across China and evaluate the probability of achieving the eradication goal. This study characterised the incidence and mortality patterns of malaria from 1950 to 2016 and carried out the epidemic trends, the results of which are valuable for disease surveillance and prevention. To understand the epidemiological characteristics of malaria among Chinese population, the sex-, age- and spatial-specific distributions were also reviewed.

Methods {#sec2}
=======

Data sources and extraction {#sec2-1}
---------------------------

The Chinese government established a routine reporting system for infectious diseases in the 1950s \[[@ref9]\]. The system was operated through administrative grading responsibility and territorial management, which was coordinated by the Chinese Centers for Disease Control and Prevention (China CDC). Data were collected from monthly paper-based reports between 1950 and 1985, and then progressed to digital monthly reports between 1985 and 2003. In response to the 2003 severe acute respiratory syndrome (SARS) epidemic, the Chinese government resolved to improve its public health disease surveillance system and build the Internet-based China Information System for Disease Control and Prevention (CISDCP), which was a real-time reporting system covering all 31 provinces and areas in mainland China \[[@ref9], [@ref10]\].

All notifiable diseases are divided into three categories (class A, B and C) according to the outbreak, prevalence and degree of harm \[[@ref11]\]. Clinicians must complete a standard case report card and report to the CISDCP when they identify any probable, clinical or laboratory-confirmed case of notifiable infectious disease within a specified timeframe. Malaria is categorised as a class B notifiable infectious disease, and diagnosed cases should be reporting within one day, case investigation within three days, and focuses investigation and action within seven days \[[@ref5]\]. Blood smear microscopic examination was the main method for malaria diagnosis, and immunological examination (2006) and polymerase chain reaction (2015) were recommended.

Data on malaria included in this study was extracted from the CISDCP system, which was established by the China CDC with open access from the Chinese Public Health Science Data Center \[[@ref12]\]. The period included in the data was from January 1950 to December 2016. Population data for mainland China were extracted from the national data \[[@ref13]\]. Province-specific population data were extracted from the China Compendium of Statistics (1950--1999) \[[@ref14]\] and the national data (2000--2016) \[[@ref13]\]. Sex- and age-specific population data (data of 2010 were not available and were replaced by the intermediate value of 2009 and 2011) were also extracted from the national data \[[@ref13]\]. Sex-, age- and type-specific data for malaria were available between 2004 and 2013. The number of indigenous malaria cases and deaths between 2017 and 2020 was estimated, from the annual per cent change (APC) values of indigenous malaria data between 2011 and 2016. No ethical approval for this study was required since the included data were publicly available and de-identified.

Statistical analysis {#sec2-2}
--------------------

The incidence (cases per 100 000 population) was defined as the annual number of cases divided by the population of the year. The mortality (deaths per 1 000 000 population) was defined as the annual number of deaths attributed to malaria divided by the population of the year. The average annual per cent change (AAPC) and APC for incidence and mortality of malaria were selected to evaluate the burden trends of disease, and estimates were calculated by the Joinpoint Regression Program version 4.6.0.0. April, 2018 (Information Management Services, Inc., Calverton, MD, USA). All average numbers are presented with the corresponding 95% confidence interval (95% CI) in brackets. The 95% CI of incidence and mortality at the national level were estimated by the Poisson regression model using SAS 9.4 software (SAS Institute Inc., Cary, NC, USA). SAS 9.4 and Origin 2017 software (Microcal Software Inc., Northampton, MA, USA) were used to draw the figures. The significance level for the hypothesis tests was set at 0.05.

Results {#sec3}
=======

Between 1950 and 2016, there were 227 668 374 cases of malaria reported in China, with an annualised average incidence of 337.024 (336.980−337.068) per 100 000 population (Supplementary Table S1). Overall, the incidence of malaria decreased with an AAPC of −11.4% (−16.6 to −6.0). The highest incidence occurred in 1970, which was 2905.704 per 100 000 ([Fig. 1](#fig01){ref-type="fig"}). Since the 1970s, the incidence of malaria has decreased rapidly with an APC of −23.9% (*t* = −18.4, *P* \< 0.05). A total of 36 085 deaths attributed to malaria were reported during the observational period (1950--2016), with an annualised average deaths of 530 (525--536). Most cases of death occurred in the 1950s, and the highest mortality was observed in 1955 (8.994 per 1 000 000). Since 1980, the annual number of malaria deaths has been under 100, and the mortality rate has been under 0.1 per 1 000 000. The overall trend of mortality decreased from 1950 to 2016 (AAPC: −8.7%, −13.7 to −3.4), and the reduction continued over the last 50 years (APC: −6.9%, −8.4 to −5.4). Fig. 1.Malaria epidemic trend in China from 1950 to 2016. Panel a: Incidence trend of malaria in China from 1950 to 2016; panel b: Mortality trend of malaria in China from 1950 to 2016.

The annualised average incidence rates were more than 500 per 100 000 in provinces such as Henan, Anhui, Jiangsu and Hubei. The rates were under 1 per 100 000 in Chongqing, Neimenggu, Ningxia, Heilongjiang, Qinghai and Jilin ([Table 1](#tab01){ref-type="table"}). Epidemics of malaria were disproportionate in different provinces and areas, and overall, districts in southern China suffered more disease burden than did other areas. The incidence rates in most provinces and areas decreased, and the AAPC values were significant (*P* \< 0.05) ([Fig. 2](#fig02){ref-type="fig"} and [Table 1](#tab01){ref-type="table"}). The annualised average mortality rate in Yunnan was the highest (3.466 per 1 000 000), and the rates in some districts, such as Guizhou, Zhejiang, Guangxi and Guangdong, were more than 1 per 1 000 000 ([Table 1](#tab01){ref-type="table"}). Mortality cases were concentrated in southern China in the 1950s. The mortality rates have been under 1 per 1 000 000 approximately since the 1970s across China (Supplementary Fig. S1). Along with the incidence of malaria, the mortality rates decreased in most provinces and areas ([Table 1](#tab01){ref-type="table"} and Supplementary Fig. S1). Fig. 2.Geographical distribution of malaria incidence in China. Table 1.Changes of incidence and mortality of malaria in each province or area in China from 1950 to 2016Province or areaCasesAnnualised average incidence 1/100 000AAPC (95% CI) %*t*/*P* valueDeathsAnnualised average mortality 1/1 000 000AAPC (95% CI) %*t*/*P* valueBeijing22 5903.0712.6 (−4.4, 10.1)0.7/0.5120.0163.4 (−2.3, 9.4)1.1/0.3Tianjin6 5871.180−6.1 (−11.1, −0.8)−2.2/\<0.0510.0021.9 (−0.2, 4.0)1.7/0.1Hebei1 824 42350.254−21.5 (−28.2, −14.1)−5.3/\<0.052100.058−10.9 (−15.3, −6.2)−4..4/\<0.05Shanxi19 9721.158−12.8 (−27.2, 4.5)−1.5/0.1470.027−9.0 (−11.1, −6.9)−8.0/\<0.05Neimenggu1 0750.088−9.7 (−12.8, −6.4)−5.6/\<0.0570.006−1.7 (−5.7, 2.4)−0.8/0.4Liaoning277 57211.958−18.7 (−28.7, −7.3)−3.1/\<0.05300.0134.4 (−17.1, 31.4)0.4/0.7Jilin9 9390.6962.1 (−74.2, 303.4)0.0/1.060.0041.9 (−13.1, 19.4)0.2/0.8Heilongjiang3 9780.201−4.8 (−8.2, −1.3)−2.7/\<0.0530.002−2.4 (−3.7, −1.0)−3.4/\<0.05Shanghai1 378 944155.020−9.6 (−15.3, −3.5)−3.0/\<0.053310.372−10.2 (−12, −8.4)−10.5/\<0.05Jiangsu34 680 179856.057−18.4 (−24.2, −12.2)−5.4/\<0.057490.185−9.6 (−11.6, −7.5)−9.0/\<0.05Zhejiang6 733 308259.522−11.9 (−15.2, −8.5)−6.5/\<0.053 6181.394−10.7 (−24.9, 6.2)−1.3/0.2Anhui29 525 149912.157−9.1 (−14.2, −3.7)−3.2/\<0.052 1740.672−17.3 (−83.3, 309.1)−0.2/0.8Fujian3 790 815216.640−24.8 (−29.9, −19.3)−8.0/\<0.057710.441−5.6 (−11.8, 1.0)−1.7/0.1Jiangxi9 348 941427.394−9.9 (−14.1, −5.5)−4.3/\<0.051 1660.533−9.2 (−13.9, −4.3)−3.6/\<0.05Shandong23 715 507473.291−18.6 (−28.7, −7.0)−3.0/\<0.053700.074−0.5 (−8.4, 8.1)−0.1/0.9Henan61 653 1741245.514−13.2 (−16.2, −10.1)−7.9/\<0.051 2940.261−9.3 (−10.7, −7.8)−11.8/\<0.05Hubei22 595 412724.554−11.3 (−14.2, −8.4)−7.3/\<0.051 3580.435−9.6 (−17.7, −0.6)−2..1/\<0.05Hunan4 822 728136.447−13.6 (−18.9, −7.9)−4.5/\<0.052 3490.665−12.9 (−15.7, −10.0)−8.5/\<0.05Guangdong8 933 887215.681−10.0 (−11.5, −8.6)−12.8/\<0.054 5581.100−10.3 (−12.7, −7.9)−7.9/\<0.05Guangxi4 069 421169.169−7.7 (−10.6, −4.8)−5.0/\<0.053 1111.293−13 (−15.5, −10.5)−9.5/\<0.05Hainan136 37735.079−19.9 (−27.1, −12.0)−4.6/\<0.05440.113−15.2 (−35.5, 11.5)−1.2/0.2Chongqing1 4970.089−9.7 (−14.1, −5.0)−4.0/\<0.0540.00217.3 (6.9--28.7)3.6/\<0.05Sichuan7 594 053164.863−13.6 (−18.4, −8.5)−5.0/\<0.052 8170.612−9.3 (−11.1, −7.4)−9.3/\<0.05Guizhou2 062 252111.369−7.1 (−10.6, −3.5)−3.8/\<0.053 1971.726−7.2 (−10.3, −4.0)−4.3/\<0.05Yunnan3 560 457163.100−3.2 (−7.3, 1.1)−1.5/0.17 5673.466−6.8 (−8.8, −4.7)−6.3/\<0.05Xizang2 6571.976−4.5 (−6.9, −2.0)−3.6/\<0.05100.074−5.0 (−18, 10.1)−0.7/0.5Shaanxi766 76239.831−7.8 (−11.1, −4.4)−4.4/\<0.051040.054−5.6 (−12.0, 1.4)−1.6/0.1Gansu37 9312.904−7.8 (−12.7, −2.5)−2.9/\<0.05510.039−7.3 (−11.0, −3.4)−3.6/\<0.05Qinghai8560.331−7.1 (−17.6, 4.7)−1.2/0.220.008−1.9 (−3.2, −0.6)−2.9/\<0.05Ningxia4820.180−3.4 (−8.4, 1.9)−1.3/0.210.004−2.9 (−4.1, −1.6)−4.6/\<0.05Xinjiang90 1089.968−14.0 (−16.0, −11.9)−12.5/\<0.051130.125−11.1 (−15, −7.1)−5.2/\<0.05[^1]

The incidence and mortality of malaria appeared in surges in different seasons, and the rates showed decreasing trends by each season ([Fig. 3](#fig03){ref-type="fig"}). During the year, the incidence rates were higher in the period from July to September than in other months. During the observational period, three peaks of incidence rates occurred in 1955, the 1960s and the 1970s. Mortality rates were higher in August through October than in other months from 1950 to 1980 and peaked in approximately 1955 and 1963. In total, 57.0% of malaria cases occurred in July through September compared to 4.1% in December through February. Additionally, 50.5% of malaria deaths occurred in August through October compared to 10.2% in January through March (Supplementary Fig. S2). Fig. 3.Seasonal distribution of malaria incidence and mortality in China. Panel a: Seasonal distribution of malaria incidence from 1950 to 2016; panel b: Seasonal distribution of malaria mortality from 1950 to 2016.

Malaria incidence rates were higher among males compared to females from 2004 to 2013, with the lowest male-to-female ratio of 1.63. The highest incidence rates among males (5.728 per 100 000) and females (3.358 per 100 000) were observed in 2006 (Supplementary Fig. S3). The distribution of malaria incidence rates among all age groups was similar during the same period. The incidence rates peaked in 2006 in all age groups. The rate was more than 6 per 100 000 in the 70--74 age group in 2006 (Supplementary Fig. S4). The incidence rates decreased among all age groups and remained continuously low in recent years (under 1 per 100 000). Since mortality rates stayed at low levels between 2004 and 2013 (236 malaria deaths reported), the sex- and age-specific rates were not reviewed.

[Table 2](#tab02){ref-type="table"} lists the reported malaria cases and deaths in China from 2011 to 2016 and the predicted cases from 2017 to 2020. There were no significant decreases in malaria incidence (APC: −4.2%, −15.5 to 8.7) or mortality (APC:−8.6%, −22.4 to 7.8), which indicated that the malaria epidemic was stable. This situation was mainly attributed to the imported cases, since the number of imported cases increased from 2011 to 2016 (APC: 11.4%, −16.3 to 47.6) and occupied the majority. The predicted number of malaria cases and deaths will decrease from 3 638 and 27 in 2011 to 2 562 and 10 in 2020, respectively. The incidence rate of indigenous cases decreased (APC: −78.1%, −89.3 to −55.4). Prediction showed that no indigenous malaria case would be reported during 2016 and 2020. Table 2.Reported and predicted malaria cases and deaths in China from 2011 to 2020YearCasesPredicted casesPredicted incidence (1/100 000)DeathsPredicted deathsPredicted mortality (1/1 000 000)Indigenous casesPredicted indigenous casesPredicted indigenous incidence (1/100 000)Imported casesPredicted imported casesPredicted imported incidence (1/100 000)20114 0883 6380.27030270.0203 3673 1660.2357214720.03520122 4513 5210.26015270.0202446910.0512 2072 8300.20920133 8963 4020.25020270.020861500.0113 8103 2520.23920142 9213 2830.24024140.01056270.0022 8653 2560.23820153 1163 1620.23020140.01039140.0013 0773 1480.22920163 1473 0420.22015140.010300.0003 1443 0420.2202017--2 9140.239--130.009--00.000--2 9140.2392018--2 7920.260--120.008--00.000--2 7920.2602019--2 6750.283--110.008--00.000--2 6750.2832020--2 5620.307--100.007--00.000--2 5620.307APC (95% CI) (2011--2016)−4.2 (−15.5, 8.7)−8.6 (−22.4, 7.8)−78.1 (−89.3, −55.4)[^a^](#tfn2_2){ref-type="table-fn"}11.2 (−16.3, 47.6)[^2][^3]

Discussion {#sec4}
==========

The trend of malaria in China between 1950 and 2016 was summarised. The incidence and mortality of malaria fluctuated during some periods. In general, the burden of malaria among the Chinese population was dramatically reduced. Consistent with this trend, the global incidence rate of malaria was estimated to have decreased by 18% between 2010 and 2017, and the WHO South-east Asia region recorded the largest decline (59%) \[[@ref4]\]. These achievements may largely be attributed to the economic development and the improvement of disease management.

Most malaria cases (92%) were in the WHO African region \[[@ref4]\]. The geographical distribution of malaria was also unbalanced within China. The high-incidence areas were mainly concentrated in central and southern areas of China (Henan, Anhui, Jiangsu, Hubei, Sichuan, Yunnan, Guangdong and Guangxi), while relatively low in northern areas. A previous study reported that the number of malaria cases in Anhui, Yunnan and Hainan provinces accounted for 77.48% of the total cases from 2006 to 2010 and concluded that provinces with high incidence rates were concentrated in central and southwestern China and Hainan \[[@ref15]\]. Furthermore, the geographical distribution of malaria tended to concentrate as time progressed from this study. It was also revealed that the spatiotemporal distribution of malaria in China changed from relatively scattered (2004--2009) to relatively clustered (2010--2014) \[[@ref16]\]. This mainly resulted from imported cases, since these imported ones from trade activities and international workers would directly increase the number of cases which were not attributed to local climate conditions or mosquitoes density. For mortality, the rates were relatively high in southern China in the 1950s, and the disparity between areas was not obvious and remained at low levels since the 1970s. Seasonal patterns of malaria in China were obvious with the incidence rate peaked in July through September and mortality peaked in August through October. Another study also showed that malaria cases were mostly concentrated in the second half of the year, particularly in July through October \[[@ref15]\].

The seasonal and geographical distribution of malaria observed might be associated with the seasonal dynamic of *Anopheles* mosquito vectors and human population distributions. National surveillance of mosquitoes showed that the mosquito density in the areas south of the Yangtze River was higher than that in other areas, and this corresponded to areas of higher malaria incidences. The density of *Anopheles* mosquitoes was peaked during June through August \[[@ref17]\]. Natural and climatic conditions in summer are more suitable for mosquitoes compared to those in winter. Additionally, the distribution of the population was regional (mainly concentrated in the southeast and central regions), which was also associated with factors such as river network density, temperature and the warming index \[[@ref18]\]. The susceptible population was consistent with that of mosquitoes, and these conditions were conducive to the occurrence of the malaria epidemic.

Males suffered more disease burden of malaria than females from this study, males accounted for 64.8%--87.0% of malaria cases in previous studies \[[@ref15], [@ref19]\]. This may be associated with the work activities, for example, farmers (mostly males) were more likely to be exposed to the environment of *Anopheles* mosquitoes. It has been observed that all age groups were at risk of malaria \[[@ref19]\]. Another study between 2006 and 2010 reported the lowest incidence rates in those under 5 years of age (1.32 per 100 000) and highest rates in those over 60 years (3.41 per 100 000) \[[@ref15]\]. The WHO concluded that children under 5 years of age and pregnant women were particularly susceptible to infection, illness and death, especially in high transmission areas \[[@ref1]\]. The susceptibility to malaria among the population was mostly related with the types of transmission (continuous, seasonal or short time). In permanent transmission areas (most African regions), adults developed the immunity and children were more susceptible. While in seasonal transmission areas, the level of exposure was not enough to build a consistent natural immunisation in adults, so the whole population expressed comparable susceptibility. In China, all age groups showed a similar susceptibility to malaria (Supplementary Fig. S4) and population at highest risk was exposed to risk factors related to work activities and location of residence \[[@ref20]\].

*P. vivax* is the dominant malaria parasite in most countries outside of sub-Saharan Africa and that *P. falciparum* is responsible for most malaria-related deaths globally \[[@ref1], [@ref3]\]. In China, *P. vivax* accounted for 76.3% (185 013 cases) of malaria incidence cases and 8.5% (207 701 cases) by *P. falciparum* between 2004 and 2013. The proportion of malaria deaths attributed to *P. falciparum* was 87.7% and 6.8% by *P. vivax*. These results were consistent with other reports \[[@ref19], [@ref21]--[@ref23]\].

China has initiated many efforts to prevent malaria and reduce the disease burden. Case reporting from the private sector was mandatory in the 1950s. Since then, many policies and strategies for intervention, diagnosis, treatment and surveillance have been adopted \[[@ref24]\]. The global fund to fight AIDS, tuberculosis and malaria has supported China between 2003 and 2012 \[[@ref7]\]. The Chinese government has covered the investment gaps since 2012 \[[@ref20]\]. The national malaria elimination action was initiated in 2010 \[[@ref25]\]. The successful control of malaria in China was mainly attributed to the country leadership efforts (national elimination strategy, community mobilisation, case-based surveillance and reference laboratory systems) and the country-led efforts (regional and inter-sectoral collaboration, sustained financial support) \[[@ref26]\]. The technical '1--3--7\' strategy, which specifies case reporting within one day, case investigation within three days and focuses investigation and action within seven days, was also rolled out and widely disseminated \[[@ref6]\]. The timeliness of the implementation of malaria surveillance and response largely improved after the strategy was integrated into the CISDCP system. Other countries with high malaria burden could learn that elimination of disease should involve country leadership and multi-sectoral cooperation.

China is listed as one of the countries that were on course for malaria elimination by 2020 \[[@ref4], [@ref8]\]. The number of malaria cases and deaths between actual and prediction were very close. In 2017, there were 2 697 malaria cases reported, among which six patients died \[[@ref27]\]. The predicted number of malaria cases was 2 914 for 2017 and 2 562 for 2020. The predicted number of deaths would decrease from 13 in 2017 to 10 in 2020. Among those cases, most of which were imported cases and became the major source of disease burden. There will be none indigenous cases during 2016 and 2020 by the prediction compared to the actual three indigenous cases from areas bordering Yunnan and Tibet in 2016, and zero in 2017 \[[@ref8]\]. In short, the goal of eliminating malaria by 2020 will be highly probable in China.

Along with the vector controlling (insecticide-treated mosquito nets and indoor residual spraying) nationwide \[[@ref1]\], China should give more attention to cross-border areas and imported malaria cases recently \[[@ref28]\]. Yunnan and the Tibet Autonomous Region were the only regions that reported locally acquired malaria cases in 2014 \[[@ref7]\]. Several high-risk counties in the long international land border still face a persistent risk of malaria introduction and transmission \[[@ref22]\]. The imported malaria cases are the key challenges to achieve malaria elimination in China \[[@ref29]\]. Since the majority of malaria infections are asymptomatic, active case detection methods in community should also be conducted to overcome the limitations of passive surveillance \[[@ref30]\]. A recent study revealed that African ape parasites in the wild are 10-fold more diverse than human *P. vivax* and exhibit no evidence of species specificity, which means that *P. vivax* will never be eradicated unless to eliminate malaria from apes, or it can cross the border at any time and cause new malaria outbreaks \[[@ref31]\]. Resurgence of malaria may occur if control and surveillance measures are scaled back too early \[[@ref32]\]. Historically, a marked increase in malaria incidence worldwide occurred as the funding was cut further \[[@ref3]\]. For China, a practical strategy should focus on the investigation and disposal of malaria case and foci in the specific areas and among the high-risk population \[[@ref33]\].

Limitation {#sec4-1}
----------

This study has several limitations. First, though long-term and wide-covered data were included in this study, the results may be underestimated since the data were passively reported. Second, epidemic characters of other types of *Plasmodium*, such as *P. ovale*, *P. malariae* and *P. knowlesi* were not involved. Third, data in the early periods are insufficient and may be less reliable than those in the later years (variations in surveillance system, data standards of collection, diagnostic levels and so on).

Conclusions {#sec5}
===========

The results of this study showed that the burden of malaria among the population in China fell drastically from 1950 to 2016. The geographical distribution of malaria was unbalanced, and a seasonal pattern was obvious. Increased attention should be paid to imported malaria cases because these cases were the major threat in recent years. Overall, the goal of malaria elimination by 2020 is a realistic aim for China.
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[^1]: AAPC, average annual percent change; 95% CI, 95% confidence interval.
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[^3]: Significant at 0.05 level; number of predicted cases from 2017 to 2020 was based on the population in 2016.
